Trial
NCT05726682
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Allogenic Stem Cell Transplantation
Intervention
SAR445419
Why stopped
Sponsor decision to cancel trial, not related to safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-05